BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Li S, Wang HY, Zeng J, Zhang ZZ, Lv DY, Kuang WH. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway. Evid Based Complement Alternat Med 2019;2019:4253846. [PMID: 31915446 DOI: 10.1155/2019/4253846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao L, Zhang S. Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects. Pharmaceuticals 2022;15:397. [DOI: 10.3390/ph15040397] [Reference Citation Analysis]
2 Luan Y, Kong X, Feng Y. Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives. Liver Research 2021;5:53-61. [DOI: 10.1016/j.livres.2021.03.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang Y, Zhang H, Wang H. Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells. Evid Based Complement Alternat Med 2021;2021:5569274. [PMID: 34055009 DOI: 10.1155/2021/5569274] [Reference Citation Analysis]